{"schema_version":"secwatch.filing_event.v1","accession":"0001551306-24-000096","form_type":"8-K","ticker":"PGNY","cik":"0001551306","company_name":"Progyny, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.927507+00:00","generated_at":"2026-06-02T05:50:48.736948+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Progyny Q1 revenue up 7.6% to $278M; cuts FY revenue guidance to $1.23-1.27B","bullets":["Q1 revenue $278.1M (+7.6% YoY), net income $16.9M ($0.17 diluted EPS), adjusted EPS $0.39.","Adjusted EBITDA $50.3M (+8%), margin 18.1% vs 17.9% prior year period.","FY 2024 revenue guidance lowered to $1.23-1.27B (from prior $1.27-1.31B) citing lower March utilization.","Repurchased 723,577 shares for $26.4M in Q1; $32M remains under $100M buyback authorization.","Clients grew 19% YoY to 451; ART cycles increased 12.4% to 14,802."],"urls":{"canonical":"https://secwatch.observer/filing/0001551306-24-000096","json":"https://secwatch.observer/filing/0001551306-24-000096.json","markdown":"https://secwatch.observer/filing/0001551306-24-000096.md","text":"https://secwatch.observer/filing/0001551306-24-000096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551306/000155130624000096/0001551306-24-000096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551306/000155130624000096/pgny-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T05:50:48.736948+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"12fc942401d2066746abd4136bdaaa2c35d4fb47","claim":"Progyny, Inc. reported the three-month period ended March 31, 2024 results: revenue $278,078, net income $16,898, EPS $0.17.","evidence_excerpt":"of February,” said Mark Livingston, Progyny’s Chief Financial Officer. First Quarter 2024 Highlights: (unaudited; in thousands, except per share amounts) 1Q 2024 1Q 2023 Revenue $278,078 $258,394 Gross Profit $62,406 $58,640 Gross Margin 22.4% 22.7% Net Income $16,898 $17,678 Net Income per Diluted Share 1 $0.17 $0.18 Adjusted Earnings Per Diluted Share 2 $0.39","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551306/000155130624000096/0001551306-24-000096-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three-month period ended March 31, 2024"},{"label":"Revenue","value":"$278,078"},{"label":"Net income","value":"$16,898"},{"label":"EPS","value":"$0.17"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}